Healthcare resource use, comorbidity, treatment and clinical outcomes for patients with primary intracranial tumors: a Swedish population-based register study

References

• Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-Oncology. 2002;4:278–299.
   PubMed Web of Science ®Google Scholar
• Asklund T, Malmstrom A, Bergqvist M, et al. Brain tumors in Sweden: data from a population-based registry 1999-2012. Acta Oncol. 2015;54:377–384.
   PubMed Web of Science ®Google Scholar
• Grapow MT, von Wattenwyl R, Guller U, et al. Randomized controlled trials do not reflect reality: real-world analyses are critical for treatment guidelines! J Thorac Cardiovasc Surg. 2006;132:5–7.
   PubMed Web of Science ®Google Scholar
• Lilja B, Miranda-Télllez J, Ljunggren G, et al. A study on cancer patients in the region of Stockholm by linking data from multiple sources. Adv Pharmacoepidemiol Drug Safety. 2015;4:187.
   Google Scholar
• Rosen M. National Health Data Registers: a Nordic heritage to public health. Scand J Public Health. 2002;30:81–85.
   PubMed Web of Science ®Google Scholar
• National Board of Health and Welfare. The Swedish Cancer Registry (database); 2013.
   Google Scholar
• Statistics Sweden: longitudinal integration database for health insurance and labour market studies (LISA by Swedish acronym); 2016.
   Google Scholar
• Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• Fritz AG. International classification of diseases for oncology: ICD-O. 3rd ed, 1st rev. ed. Geneva: World Health Organization; 2013. p. viii, 242.
   Google Scholar
• The National Board of Health and Welfare. Causes of Death (database); 2016.
   Google Scholar
• Carlsson AC, Wandell P, Osby U, et al. High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden – a challenge for public health. BMC Public Health. 2013;13:670.
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.
   PubMed Web of Science ®Google Scholar
• Swedish national care program: high-grade gliomas; 2012. [cited 2012 Aug]. Available from: http://www.cancercentrum.se/globalassets/cancerdiagnoser/hjarna/vardprogram/natvp_hjarntumorer_20120829_final.pdf.
   Google Scholar
• Islam KM, Jiang X, Anggondowati T, et al. Comorbidity and survival in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2015;24:1079–1085.
   PubMed Web of Science ®Google Scholar
• Iversen LH, Norgaard M, Jacobsen J, et al. The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006–a population-based cohort study. Dis Colon Rectum. 2009;52:71–78.
   PubMed Web of Science ®Google Scholar
• Lemmens VE, Janssen-Heijnen ML, Verheij CD, et al. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg. 2005;92:615–623.
   PubMed Web of Science ®Google Scholar
• Zarnett OJ, Sahgal A, Gosio J, et al. Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis. JAMA Neurol. 2015;72:589–596.
   PubMed Web of Science ®Google Scholar
• Malmstrom A, Gronberg BH, Marosi C, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol. 2012;13:916–926.
   PubMed Web of Science ®Google Scholar
• Asklund T, Malmstrom A, Bjor O, et al. Considerable improvement in survival for patients aged 60-84 years with high grade malignant gliomas: data from the Swedish Brain Tumour Population-based Registry. Acta Oncol. 2013;52:1041–1043.
   PubMed Web of Science ®Google Scholar
• Ewing M, Naredi P, Nemes S, et al. Increased consultation frequency in primary care, a risk marker for cancer: a case-control study. Scand J Prim Health Care. 2016;34:205–212.
   PubMed Web of Science ®Google Scholar
• Torring ML, Frydenberg M, Hansen RP, et al. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer. 2013;49:2187–2198.
   PubMed Web of Science ®Google Scholar
• Jensen H, Torring ML, Olesen F, et al. Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study. BMC Cancer. 2014;14:636.
   PubMed Web of Science ®Google Scholar
• Dolecek TA, Propp JM, Stroup NE, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol. 2012;14(Suppl 5):v1–49.
   PubMed Web of Science ®Google Scholar
• Weller M, van den Bent M, Hopkins K, et al. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol. 2014;15:e395–e403.
   PubMed Web of Science ®Google Scholar